{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:16:35Z","timestamp":1783577795885,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to characterize fluoroquinolone (FQs) resistance and associated gene mutations in\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      (MTB) isolates from Fujian Province, with the goal of providing evidence to support precise prevention and control strategies for drug-resistant tuberculosis (TB).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was performed on 150 clinical MTB isolates collected from drug resistance surveillance sites. Phenotypic drug susceptibility testing (pDST) for FQs was conducted using the proportion method on solid L\u00f6wenstein\u2013Jensen (L\u2013J) media. In parallel, whole-genome sequencing (WGS) was applied to identify resistance-associated gene mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall phenotypic resistance rate to FQs was 12.7%, increasing markedly to 26.7% among multidrug-resistant (MDR) strains. The isolates were mainly classified into lineage L2 (60.0%) and L4 (38.7%), with no statistically significant association observed between lineage distribution and drug resistance profiles. Mutations linked to FQs resistance were predominantly identified in the\n                      <jats:italic>gyrA<\/jats:italic>\n                      gene (81.8%), primarily occurring at codons 90, 91, and 94. Notably, mutations were also detected in seven phenotypically susceptible isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      FQs resistance among MTB isolates in this study is considerable, with a particularly high burden in MDR strains. Resistance is mainly driven by single-point mutations in the\n                      <jats:italic>gyrA<\/jats:italic>\n                      gene. Importantly, WGS demonstrates potential for identifying resistance-associated mutations even in phenotypically susceptible isolates, offering valuable insights for early warning of emerging drug resistance and optimization of treatment strategies for MDR\/RR-TB.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1890292","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:36Z","timestamp":1783575276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluoroquinolone resistance and mutation profiles in Mycobacterium tuberculosis through whole genome sequencing in Fujian province, China"],"prefix":"10.3389","volume":"14","author":[{"given":"Yongming","family":"Lin","sequence":"first","affiliation":[{"name":"Fujian Provincial Center for Disease Control and Prevention","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Fujian Provincial Center for Disease Control and Prevention","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[{"name":"Fujian Provincial Center for Disease Control and Prevention","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Lin","sequence":"additional","affiliation":[{"name":"Fujian Provincial Center for Disease Control and Prevention","place":["Fuzhou, China"]},{"name":"Fujian Provincial Key Laboratory of Zoonosis Research","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisong","family":"Dai","sequence":"additional","affiliation":[{"name":"Fujian Provincial Center for Disease Control and Prevention","place":["Fuzhou, China"]},{"name":"Fujian Provincial Key Laboratory of Zoonosis Research","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Wei","sequence":"additional","affiliation":[{"name":"Fujian Provincial Center for Disease Control and Prevention","place":["Fuzhou, China"]},{"name":"Fujian Provincial Key Laboratory of Zoonosis Research","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref1","year":"2024"},{"key":"ref2","year":"2025"},{"key":"ref3","year":"2025"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3201\/eid3103.241675","article-title":"Fluoroquinolone resistancein drug-resistant tuberculosis, Kharkiv, Ukraine, 2019\u20132023","volume":"31","author":"Konstantynovska","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/cid\/ciae560","article-title":"Population-level frequency of fluoroquinolone resistance by whole-genome sequencing drug predictions in Mycobacterium tuberculosis complex isolates in England from 2017 through 2023","volume":"80","author":"Ferran","year":"2025","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e31959","DOI":"10.1016\/j.heliyon.2024.e31959","article-title":"Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates","volume":"10","author":"Teng","year":"2024","journal-title":"Heliyon"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.19982\/j.issn.1000-6621.20240133","article-title":"Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains","volume":"46","author":"Yu","year":"2024","journal-title":"Chin J Antituberc"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2302837","DOI":"10.1080\/22221751.2024.2302837","article-title":"Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study","volume":"13","author":"Li","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jiph.2023.11.018","article-title":"The emerging threat of fluoroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: observations on surveillance data","volume":"17","author":"Li","year":"2023","journal-title":"J Infect Public Health"},{"key":"ref10","first-page":"1","article-title":"Trends and influencing factors of rifampicin resistance in pulmonary tuberculosis patients in Fujian Province","volume":"30","author":"Chen","year":"2024","journal-title":"Strait J Prev Med"},{"key":"ref11","first-page":"1","article-title":"Consistency of anti-tuberculosis treatment regimens with standard treatment regimens and influencing factors in county-level designated hospitals in Fujian Province","volume":"31","author":"Chen","year":"2025","journal-title":"Strait J Prev Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9266","DOI":"10.1038\/s41598-026-40398-6","article-title":"First insight of characteristics and prediction of Mycobacterium tuberculosis drug resistance by whole genome sequencing in Fujian Province, China","volume":"16","author":"Wei","year":"2026","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.2147\/IDR.S380950","article-title":"The emergence of novel spoligotypes of highly drug-resistant isolates in Fujian, China","volume":"15","author":"Lin","year":"2022","journal-title":"Infect Drug Resist"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.lanwpc.2021.100106","article-title":"A population-based genomic epidemiological study of the source of tuberculosis infections in an emerging city: Shenzhen, China","volume":"8","author":"Yang","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"bbac030","DOI":"10.1093\/bib\/bbac030","article-title":"SAM-TB: a whole genome sequencing data analysis website for detection of Mycobacterium tuberculosis drug resistance and transmission","volume":"23","author":"Yang","year":"2022","journal-title":"Brief Bioinform"},{"key":"ref16","year":"2021"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106648","DOI":"10.1016\/j.jinf.2025.106648","article-title":"Association between pre-diagnostic fluoroquinolone exposure and possible acquired fluoroquinolone resistance in MTB in Shanghai","author":"Zhang","year":"2025","journal-title":"J Infect"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1021\/acs.est.5b00729","article-title":"Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modelling, and linkage to bacterial resistance","volume":"49","author":"Zhang","year":"2015","journal-title":"Environ Sci Technol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/molbev\/msz214","article-title":"The genetic background modulates the evolution of fluoroquinolone-resistance in Mycobacterium tuberculosis","volume":"37","author":"Castro","year":"2020","journal-title":"Mol Biol Evol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2147\/IDR.S361635","article-title":"Characterization of fluoroquinolone-resistant and multidrug-resistant Mycobacterium tuberculosis isolates using whole-genome sequencing in Tianjin, China","volume":"15","author":"Wang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S1473-3099(22)00875-1","article-title":"Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet\/RESIST-TB consensus statement","volume":"23","author":"Dom\u00ednguez","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2023.04.392","article-title":"Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"132","author":"Diriba","year":"2023","journal-title":"Int J Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e02170","DOI":"10.1128\/AAC.02170-16","article-title":"Genotyping and prevalence of pyrazinamide- and moxifloxacin-resistant tuberculosis in China, 2000 to 2010","volume":"61","author":"Pang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijid.2020.01.021","article-title":"Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene","volume":"92","author":"Huo","year":"2020","journal-title":"Int J Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2024.1413618","article-title":"Surveillance of fluoroquinolones resistance in rifampicin-susceptible tuberculosis in eastern China with whole-genome sequencing-based approach","volume":"15","author":"Che","year":"2024","journal-title":"Front Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3969\/j.issn.1002-2694.2016.010.005","article-title":"Phenotypic fluoroquinolones resistance and characteristics of gyrA mutation in MDR Mycobacterium tuberculosis isolates in Fujian Province","volume":"32","author":"Wei","year":"2016","journal-title":"Chin J Zoonoses"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3103\/S0891416823020027","article-title":"Association of mutations in gyrA gene with resistance to fluoroquinolones in clinical isolates of multidrug-resistant Mycobacterium tuberculosis","volume":"38","author":"Hanieh","year":"2023","journal-title":"Mol Genet Microbiol Virol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"19719","DOI":"10.1038\/s41598-024-70535-y","article-title":"Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study","volume":"14","author":"Nehru","year":"2024","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3969\/j.issn.1000-6621.2018.10.006","article-title":"Prevalence and molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to fluoroquinolones in Chongqing","volume":"40","author":"Hu","year":"2018","journal-title":"Chin J Antituberc"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0355523","DOI":"10.1128\/spectrum.03555-23","article-title":"Transmission of multidrug-resistant tuberculosis in Jiangxi, China, and associated risk factors","volume":"12","author":"Zhan","year":"2024","journal-title":"Microbiol Spectrum"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"874","DOI":"10.7683\/xxyxyxb.2018.10.007","article-title":"Correlation between phenotypic resistance to fluoroquinolones and gyrA and gyrB gene mutations in multidrug-resistant Mycobacterium tuberculosis in Zhengzhou, China","volume":"35","author":"Liang","year":"2018","journal-title":"J Xinxiang Med Univ"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ijantimicag.2019.08.005","article-title":"Beijing genotype of Mycobacterium tuberculosis is less associated with drug resistance in South China","volume":"54","author":"Zhao","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1186\/s12864-021-08139-3","article-title":"The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia","volume":"22","author":"Maladan","year":"2021","journal-title":"BMC Genomics"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1017\/S095026882100279X","article-title":"Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance","volume":"150","author":"Wang","year":"2022","journal-title":"Epidemiol Infect"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e01543-21","DOI":"10.1128\/spectrum.01543-21","article-title":"Drug-resistant characteristics, genetic diversity, and transmission dynamics of rifampicin-resistant Mycobacterium tuberculosis in Hunan, China, revealed by whole-genome sequencing","volume":"10","author":"He","year":"2021","journal-title":"Microbiol Spectrum"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"11626","DOI":"10.1038\/s41598-025-90089-x","article-title":"Diagnostic accuracy of nanopore sequencing for detecting mycobacterium tuberculosis and drug-resistant strains: a systematic review and meta-analysis","volume":"15","author":"Carandang","year":"2025","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e0008226","DOI":"10.1128\/jcm.00082-26","article-title":"Evaluation of the Deeplex Myc-TB targeted next-generation sequencing assay for mycobacterial identification and drug resistance detection","author":"Notarte","year":"2026","journal-title":"J Clin Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsre\/fuab050","article-title":"Critical discussion on drug efflux in Mycobacterium tuberculosis","volume":"46","author":"Remm","year":"2022","journal-title":"FEMS Microbiol Rev"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1890292\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:40Z","timestamp":1783575280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1890292\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":38,"alternative-id":["10.3389\/fpubh.2026.1890292"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1890292","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1890292"}}